The study is enrolling 60 healthy volunteers aged 18-45, but the company hopes it will form the basis of trials of the drug as an outpatient treatment for patients who do not require hospitalization. Remdesivir is currently administered via IV. MedCityNews
Monday, July 13, 2020
Gilead starts Phase I trial of inhaled version of Covid-19 drug remdesivir
The study is enrolling 60 healthy volunteers aged 18-45, but the company hopes it will form the basis of trials of the drug as an outpatient treatment for patients who do not require hospitalization. Remdesivir is currently administered via IV. MedCityNews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment